344 related articles for article (PubMed ID: 3869424)
1. Are plasma lipoproteins responsible for the excess atherosclerosis in diabetes?
Nikkilä EA
Acta Endocrinol Suppl (Copenh); 1985; 272():27-30. PubMed ID: 3869424
[TBL] [Abstract][Full Text] [Related]
2. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.
Oki JC
Pharmacotherapy; 1995; 15(3):317-37. PubMed ID: 7667166
[TBL] [Abstract][Full Text] [Related]
3. Diabetic dyslipidemia and atherosclerosis.
Shepherd J
Schweiz Med Wochenschr; 1994 Nov; 124(44):1933-7. PubMed ID: 7973520
[TBL] [Abstract][Full Text] [Related]
4. Effect of metabolic control of the serum lipid and lipoprotein levels on insulin-dependent diabetes mellitus.
Romics L; Karádi I; Rozenberczki M; Kammerer L
Acta Med Acad Sci Hung; 1982; 39(3-4):117-23. PubMed ID: 6764327
[TBL] [Abstract][Full Text] [Related]
5. [Triglyceride-rich lipoproteins as risk factors for atherosclerosis].
Schwandt P
Klin Wochenschr; 1990; 68 Suppl 22():54-8. PubMed ID: 2087080
[TBL] [Abstract][Full Text] [Related]
6. The effects of glibenclamide and insulin on plasma high density lipoprotein in diabetics.
Tamai T; Nakai T; Yamada S; Kobayashi T; Hayashi T; Kutsumi Y; Oida K; Takeda R
Artery; 1981; 9(6):477-93. PubMed ID: 6802107
[TBL] [Abstract][Full Text] [Related]
7. [Changes in serum lipoproteins in cerebrovascular disease (author's transl)].
Bruck J; Fischer M; Tschabitscher H
Wien Klin Wochenschr; 1981 Oct; 93(19):604-9. PubMed ID: 7324470
[TBL] [Abstract][Full Text] [Related]
8. Effects of short-term modest weight loss on fasting and post-prandial lipoprotein sub-fractions in type 2 diabetes mellitus patients.
Ybarra J; James RW; Makoundou V; Bioletto S; Golay A
Diabetes Metab; 2001 Dec; 27(6):701-8. PubMed ID: 11852380
[TBL] [Abstract][Full Text] [Related]
9. Lipoprotein alterations in hemodialysis: differences between diabetic and nondiabetic patients.
González AI; Schreier L; Elbert A; Berg G; Beresan H; López G; Wikinski R
Metabolism; 2003 Jan; 52(1):116-21. PubMed ID: 12524671
[TBL] [Abstract][Full Text] [Related]
10. Very low density lipoprotein. Qualitative abnormalities in patients with premature coronary heart disease and in patients with insulin dependent diabetes.
Mancini M; Pauciullo P; Cortese C; Rubba P; Riccardi G; Rivellese A
Horm Metab Res Suppl; 1988; 19():13-5. PubMed ID: 3235056
[TBL] [Abstract][Full Text] [Related]
11. Management of hypercholesterolaemia in the patient with diabetes.
Packard C; Olsson AG
Int J Clin Pract Suppl; 2002 Jul; (130):27-32. PubMed ID: 12296606
[TBL] [Abstract][Full Text] [Related]
12. Dyslipidaemia in diabetes mellitus. Review of the main lipoprotein abnormalities and their consequences on the development of atherogenesis.
Vergès BL
Diabetes Metab; 1999 Jun; 25 Suppl 3():32-40. PubMed ID: 10421991
[TBL] [Abstract][Full Text] [Related]
13. Plasma lipoprotein composition in type 2 diabetic patients.
Møller A; Rasmussen L; Ledet T
Scand J Clin Lab Invest; 1987 Nov; 47(7):731-8. PubMed ID: 3685873
[TBL] [Abstract][Full Text] [Related]
14. Very low density lipoproteins in type II diabetes mellitus and risk of atherosclerosis.
Schwandt P
Horm Metab Res Suppl; 1985; 15():80-3. PubMed ID: 3865885
[TBL] [Abstract][Full Text] [Related]
15. Diabetic dyslipidemia.
Chahil TJ; Ginsberg HN
Endocrinol Metab Clin North Am; 2006 Sep; 35(3):491-510, vii-viii. PubMed ID: 16959582
[TBL] [Abstract][Full Text] [Related]
16. Serum lipoproteins in patients with clinical signs of atherosclerosis: peripheral vascular and coronary heart disease.
Kaliman J; Widhalm K; Strobl W
Artery; 1980; 8(6):547-52. PubMed ID: 7259533
[TBL] [Abstract][Full Text] [Related]
17. Adverse effects of obesity on lipid and lipoprotein levels in insulin-dependent and non-insulin-dependent diabetes.
Laakso M; Pyörälä K
Metabolism; 1990 Feb; 39(2):117-22. PubMed ID: 2299984
[TBL] [Abstract][Full Text] [Related]
18. Pharmacologic treatment of type 2 diabetic dyslipidemia.
Moon YS; Kashyap ML
Pharmacotherapy; 2004 Dec; 24(12):1692-713. PubMed ID: 15585439
[TBL] [Abstract][Full Text] [Related]
19. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R
Artery; 1982; 10(4):266-85. PubMed ID: 7181672
[TBL] [Abstract][Full Text] [Related]
20. Improved lipoprotein surface and core lipid composition following intraperitoneal insulin delivery in insulin-dependent diabetes mellitus.
Bagdade JD; Dunn FL
Diabetes Metab; 1996 Dec; 22(6):420-6. PubMed ID: 8985650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
